Advertisement

Cancer Talk

  • Clinical Trials: An African American Survivor’s Experience  

    Clinical Trials: An African American Survivor’s Experience

    Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

    by Melvin Mann
  • Food Insecurity and Cancer  

    Food Insecurity and Cancer

    After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank.

    by Jen Tota McGivney
  • “Congrats! You Have the ‘Good’ Cancer”  

    “Congrats! You Have the ‘Good’ Cancer”

    Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

    by Carly Flumer
  • Progress, But Still Room for Improvement  

    Progress, But Still Room for Improvement

    The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.

    by Kevin McLaughlin
Advertisement

From the AACR

  • Experts' Forecast: 2020

    As a new decade begins to unfold, what advancements can we expect in the field of oncology?

  • New FDA Approval

    The U.S. Food and Drug Administration expanded the use of a targeted therapeutic to include treating certain patients with pancreatic cancer.

  • 2019 in Review

    Research continued to drive progress across the spectrum of cancer care in the form of new ways to prevent, detect, diagnose, and treat the disease.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR

Cancer Progress Report

The AACR Cancer Progress Report 2019, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.

Supporters

... ... ... ... ... ...